According to these results, the search for a relationship between the overexpression of APP, S100B, and IL-1β resulted in experiments showing that the activation of glia and the resultant increase of IL-1β and S100B in the nervous system influences the neuropathogenesis of both AD and DS. The gene discussed is APP; the disease is Alzheimer disease.